Product

Shingrix®

1 clinical trial

4 indications

Indication
Herpes Zoster
Indication
Herpes zoster
Indication
Varicella
Clinical trial
Systems Biology of Zoster Vaccine Recombinant, Adjuvanted (SHINGRIX)
Status: Completed, Estimated PCD: 2023-04-03